Greenyn Biotechnology Co., Ltd
TWO: 6846.TWO0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Taipei Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Pang Kuei Hsu
- Employees
- 143
- Headquarters
- Taichung, Taiwan
- IPO year
- 2022
- Market cap
- NT$1.9B
- Website
- https://www.greenynbio.com
Loading 6846…
Loading profile data…Frequently asked questions about 6846
What does Greenyn Biotechnology Co., Ltd (6846.TWO) do?
Greenyn Biotechnology Co., Ltd, a dietary supplement company, develops, manufactures, and sells health products in Taiwan and internationally. The company offers proprietary ingredients, such as Insumate, a bitter melon extract; Antromax, an antrodia cinnamomea; and Zymologist 101 Phyto fermented drink. It also provides functional formulas for y...
Where does 6846.TWO trade?
Greenyn Biotechnology Co., Ltd (6846.TWO) trades on the Taipei Exchange.
What sector is 6846.TWO in?
Greenyn Biotechnology Co., Ltd (6846.TWO) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Greenyn Biotechnology Co., Ltd?
Pang Kuei Hsu is the chief executive officer of Greenyn Biotechnology Co., Ltd (6846.TWO).
Where is Greenyn Biotechnology Co., Ltd headquartered?
Greenyn Biotechnology Co., Ltd is headquartered in Taiwan.
Does 6846.TWO pay a dividend?
Yes — Greenyn Biotechnology Co., Ltd (6846.TWO) paid a trailing twelve-month dividend of TWD 3.60 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 6846.TWO go public?
Greenyn Biotechnology Co., Ltd (6846.TWO) completed its initial public offering in 2022.